Outcomes of Zoledronic Acid Use in Paediatric Conditions
Conclusion: This is the largest cohort of reported outcomes of ZA use in a paediatric population. Results demonstrate a good efficacy profile and associated improved bone density for osteoporotic conditions and stabilization of non-traumatic AVN with a low rate of joint collapse.Horm Res Paediatr
Source: Hormone Research in Paediatrics - Category: Endocrinology Source Type: research
More News: Back Pain | Children | Endocrinology | Hormones | Orthopaedics | Osteogenesis Imperfecta (brittle bone disease) | Osteoporosis | Pain | Pediatrics | Reclast | Zometa